Vitamin D insufficiency linked to increased periodontal destruction and inflammation in well-controlled type-2 diabetes patients
Background
Periodontitis, a chronic inflammatory disease affecting tooth-supporting tissues, is more prevalent and severe in individuals with type-2 diabetes (T2DM). This bidirectional relationship complicates disease management, as chronic inflammation from periodontitis can worsen glycemic control. Vitamin D plays a crucial role in immune modulation, bone metabolism, and anti-inflammatory processes, with its deficiency linked to various chronic diseases. Understanding the specific interplay between systemic vitamin D status and local periodontal inflammation in well-controlled diabetic patients is vital for developing comprehensive treatment strategies.
Study Design
Researchers investigated 41 well-controlled T2DM patients with periodontitis, dividing them into two groups: 26 with Vitamin D insufficiency (Vit.D-IS) and 15 with Vitamin D sufficiency (Vit.D-S). Clinical periodontal parameters including papilla bleeding index, bleeding on probing (BOP), supragingival plaque, clinical attachment level (CAL), and probing depth (PD) were assessed. Gingival crevicular fluid (GCF) total amounts of 25(OH)D3, 1,25(OH)2D3, LL-37 (cathelicidin), and TNF-α were quantified using ELISA. Serum 25(OH)D3 levels were precisely determined via liquid chromatography tandem-mass spectrometry.
Results
Patients in the Vit.D-IS group exhibited significantly worse periodontal health compared to the Vit.D-S group. Whole mouth CAL scores were higher in the Vit.D-IS group (P=0.038), as were whole mouth BOP scores (P=0.048). Serum 25(OH)D3 levels showed a direct inverse association with clinical parameters, being adversely correlated with CAL (P=0.018) and BOP scores (P=0.049). Interestingly, whole mouth PD and plaque values were comparable between both groups. No significant differences were detected in GCF levels of 25(OH)D3, 1,25(OH)2D3, LL-37, or TNF-α between the Vit.D-IS and Vit.D-S groups, suggesting systemic vitamin D status primarily influences clinical outcomes rather than local GCF concentrations of these markers. However, a strong positive relationship was observed between GCF 1,25(OH)2D3 total amounts and GCF LL-37 total amounts (P=0.0001), indicating a local regulatory link between active vitamin D and the antimicrobial peptide LL-37 within the gingival tissue.
Serum 25(OH)D3 insufficiency was significantly related to periodontal inflammation and destruction in periodontitis patients with well-controlled T2DM.
Key Findings
- Whole mouth
CALscores were higher in Vit.D-insufficient T2DM patients with periodontitis (P=0.038). - Whole mouth
BOPscores were higher in Vit.D-insufficient T2DM patients with periodontitis (P=0.048). - Serum
25(OH)D3levels inversely correlated withCAL(P=0.018) andBOP(P=0.049). - GCF
1,25(OH)2D3positively correlated with GCFLL-37total amounts (P=0.0001). - No significant differences in GCF
25(OH)D3,1,25(OH)2D3,LL-37, orTNF-αlevels were found between groups.
Why It Matters
This study underscores the critical role of systemic vitamin D levels in managing periodontitis in type-2 diabetes patients. Maintaining adequate serum vitamin D could serve as a simple, non-invasive adjunct to conventional periodontal therapy, potentially improving clinical outcomes like reduced attachment loss and bleeding. For individuals with T2DM and periodontitis, particularly those with vitamin D deficiency, integrating periodontal health into their diabetic treatment protocol becomes even more crucial. While the study didn't involve a vitamin D intervention, it strongly suggests that addressing vitamin D insufficiency could be a practical step to mitigate periodontal disease progression in this vulnerable population, complementing existing dental and diabetes care strategies.
vitamin d
periodontitis
type-2-diabetes
inflammation
observational
clinical-study